Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. FibroBiologics Inc shares valued at $16,800 were purchased by Khoja Hamid on May 27 ’25. At $0.84 per share, Khoja Hamid acquired 20,000 shares. The insider’s holdings grew to 31,250 shares worth approximately $16250.0 following the completion of this transaction.
As published in their initiating research note from Rodman & Renshaw on December 12, 2024, FibroBiologics Inc [FBLG] has been a Buy and the price target has been revised to $12. Analysts at H.C. Wainwright started covering the stock with ‘”a Buy”‘ outlook in a report released in late October. As of September 24, 2024, Maxim Group has initiated its “Buy” rating for FBLG.
Analyzing FBLG Stock Performance
On last trading session, FibroBiologics Inc [NASDAQ: FBLG] plunged -4.23% to $0.52. The stock’s lowest price that day was $0.5122, but it reached a high of $0.56 in the same session. During the last five days, there has been a drop of approximately -13.16%. Over the course of the year, FibroBiologics Inc shares have dropped approximately -83.60%. Shares of the company reached a 52-week high of $2.3350 on 01/07/25 and a 52-week low of $0.5100 on 09/23/25.
Support And Resistance Levels for FibroBiologics Inc (FBLG)
According to the 24-hour chart, there is a support level at 0.5029, which, if violated, would cause prices to drop to 0.4826. In the upper region, resistance lies at 0.5517. The next price resistance is at 0.5802. RSI (Relative Strength Index) is 43.81 on the 14-day chart, showing neutral technical sentiment.
Is FibroBiologics Inc subject to short interest?
Stocks of FibroBiologics Inc saw a sharp steep in short interest on 2025-09-15 dropping by -0.13 million shares to 0.97 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 1.1 million shares. A decline of -13.19% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.24 of the overall float, the days-to-cover ratio (short ratio) decline to 2.24.
Which companies own the most shares of FibroBiologics Inc (FBLG)?
In terms of FibroBiologics Inc share price expectations, FactSet research, analysts set an average price target of 9 in the next 12 months, up nearly 1536.36% from the previous closing price of $0.55. Analysts anticipate FibroBiologics Inc stock to reach 9 by 2025, with the lowest price target being 9.
